Hemoglobin A1c-systolic blood pressure index as a novel predictor of cardiovascular disease: evidence from three prospective cohorts - PubMed
5 days ago
- #cardiovascular disease
- #diabetes
- #hypertension
- Study introduces Hemoglobin A1c-Systolic Blood Pressure Index (HSI) as a novel predictor for cardiovascular disease (CVD).
- HSI combines HbA1c and systolic blood pressure (SBP) to assess glucose and blood pressure status simultaneously.
- Data from three cohorts (CHARLS, ELSA, HRS) show higher HSI correlates with increased CVD risk.
- Cumulative HSI also significantly associated with elevated CVD risk across all cohorts.
- HSI's predictive performance for CVD surpasses using HbA1c or SBP alone.
- Findings suggest HSI as a pragmatic tool for integrated cardiometabolic risk assessment.